Trial Profile
A Randomized, Open-Label, Neoadjuvant Prostate Cancer Trial of Abiraterone Acetate Plus LHRHa Versus LHRHa Alone.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Leuprorelin; Prednisone
- Indications Adenocarcinoma; Prostate cancer
- Focus Biomarker; Therapeutic Use
- Sponsors Cougar Biotechnology
- 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Dec 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center record.